On this page
What each program costs in Illinois
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.2 (218 reviews) | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 11 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 12 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 13 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 14 | Microdosing Tirzepatide | 12-month plan, $2,028 up front | $169/mo | none | 4.0 (162 reviews) | Visit | ||
| 15 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 16 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 17 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 18 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 19 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
Does the Illinois State Employees Group Insurance Program cover GLP-1s for weight loss?
Illinois state employee plans cover medically necessary injectable medication for weight loss for adults with prediabetes, gestational diabetes or obesity, under state law. After the first prescription the member must enroll in, and stay in, a lifestyle management program or coverage is denied.
Illinois Department of Central Management Services
Central Management Services says all plans in the program cover injectable weight-loss medication for adults with prediabetes, gestational diabetes or obesity.
“all health plans under the State Employees Group Insurance Program will provide coverage for all types of medically necessary injectable medication prescribed to improve glucose or weight loss for use by adults (age 18 and over) that have been diagnosed with prediabetes, gestational diabetes, or obesity.”
https://cms.illinois.gov/benefits/stateemployee/summaryofbenefitsandcoverage.html · read Oct 29, 2026
Illinois Department of Central Management Services
Coverage depends on enrolling in the plan's lifestyle management program.
“If you fail to enroll or continue to participate in the LMP, future coverage will be denied.”
https://cms.illinois.gov/benefits/stateemployee/summaryofbenefitsandcoverage.html · read Oct 29, 2026
What do Illinois's big insurers publish on Wegovy and Zepbound?
Blue Cross and Blue Shield of Illinois
Blue Cross and Blue Shield of Illinois treats GLP-1 weight-management coverage as an optional choice for employer groups. From November 1, 2026, self-funded groups with Prime Therapeutics that cover these drugs can set a $150 member cost share for up to a 30-day supply.
Blue Cross and Blue Shield of Illinois
In a May 20, 2026 note for self-funded groups, Blue Cross and Blue Shield of Illinois says GLP-1 weight-management coverage is optional for the plan.
“As with other GLP‑1s for weight management, plan coverage is optional with utilization management and metabolic health programs are available to drive safe and clinically appropriate use.”
https://www.bcbsil.com/producer/news/05-20-26-new-glp1-coverage-2026 · read Oct 29, 2026
Blue Cross and Blue Shield of Illinois
An October 9, 2026 employer notice adds a $150 member cost-share option from November 1, 2026 for self-funded groups that cover these drugs.
“Beginning Nov. 1, 2026, self-funded groups with Prime Therapeutics® that cover GLP-1 weight-management drugs can elect a new, $150 member cost-share benefit.”
https://www.bcbsil.com/employer/news/10-09-26-greater-flexibility · read Oct 29, 2026
Does Illinois Medicaid cover GLP-1s for weight loss?
Not covered for weight loss
Illinois Medicaid's drug list says Wegovy is covered for heart risk and a liver condition only, Zepbound for sleep apnea only, and neither will be covered for weight loss alone. Read from state documents Nov 6, 2026.
What Illinois Medicaid's documents say about each drug for weight loss. Read Nov 6, 2026. Illinois Department of Healthcare and Family Services.
WegovyNo
Non-preferred. Covered for MACE reduction and MASH with prior authorization; tablets for MACE only.
“*Wegovy covered for MACE & MASH only. *Zepbound covered for OSA only. *Wegovy and Zepbound will not be covered for weight loss alone.”
Illinois Department of Healthcare and Family Services · Effective Oct 20, 2026 · read Nov 6, 2026
“Not covered agents (weight loss only):”
Illinois HFS fee-for-service prior authorization criteria (listed on ilpriorauth.com, hosted on Box) · Effective Oct 1, 2026 · read Nov 6, 2026
ZepboundNo
Non-preferred. Covered for obstructive sleep apnea with prior authorization.
“*Wegovy covered for MACE & MASH only. *Zepbound covered for OSA only. *Wegovy and Zepbound will not be covered for weight loss alone.”
Illinois Department of Healthcare and Family Services · Effective Oct 20, 2026 · read Nov 6, 2026
“Not covered agents (weight loss only):”
Illinois HFS fee-for-service prior authorization criteria (listed on ilpriorauth.com, hosted on Box) · Effective Oct 1, 2026 · read Nov 6, 2026
OzempicNo
Non-preferred, with step therapy. The fee-for-service criteria read for this drug list type 2 diabetes uses only.
“Ozempic (semaglutide) - injectable GLP1-RA - Step 8”
Illinois HFS fee-for-service prior authorization criteria (listed on ilpriorauth.com, hosted on Box) · Effective Oct 1, 2026 · read Nov 6, 2026
“Glycemic control in adults with T2DM as an adjunct to diet and exercise”
Illinois HFS fee-for-service prior authorization criteria (listed on ilpriorauth.com, hosted on Box) · Effective Oct 1, 2026 · read Nov 6, 2026
MounjaroNo
Non-preferred, with step therapy. The fee-for-service criteria read for this drug list type 2 diabetes uses only.
“Mounjaro (tirzepatide) - injectable GIP/GLP1-RA - Step 8”
Illinois HFS fee-for-service prior authorization criteria (listed on ilpriorauth.com, hosted on Box) · Effective Oct 1, 2026 · read Nov 6, 2026
“Glycemic control in adults with T2DM as an adjunct to diet and exercise”
Illinois HFS fee-for-service prior authorization criteria (listed on ilpriorauth.com, hosted on Box) · Effective Oct 1, 2026 · read Nov 6, 2026
This reports what the documents say. It is not medical or legal advice: your plan and your prescriber decide.
What changed, and when
- Nov 6, 2026 · This pageFirst read from Illinois Department of Healthcare and Family Services documents. KFF's January 2026 map listed this program as not covered; the documents we read agree.
Weight loss
Not covered, read Nov 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
3,046 prescriptions
Ozempic and Mounjaro, 2025
64,991 prescriptions
Neighbours covering weight loss
2 of 5
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. A state document may not settle every plan; if your Illinois Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
For comparison, a dated secondary source: KFF's January 2026 map listed Illinois Medicaid as "not covered" for GLP-1s for obesity under fee-for-service.
The BALANCE model
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether Illinois Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does Illinois Medicaid pay for?
288,470 GLP-1 prescriptions in 2025, 9th of the 50 states and DC, with $300.8 million reimbursed before rebates. Counting the share other payers covered, $305.5 million.
Prescriptions, 2025
288,470
9th of 51
Medicaid paid
$300.8M
9th of 51, before rebates
Per prescription
$1,043
$1,051 nationally
Weight-loss brands
1.1%
38th highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. Illinois is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 1.1% of Illinois Medicaid's GLP-1 prescriptions in 2025 (3,046). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Trulicity was Illinois Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Trulicity | 178,820 | 62% | $191.2 million | $1,069 |
| Mounjaro | 34,435 | 12% | $37.2 million | $1,081 |
| Ozempic | 30,556 | 11% | $31.3 million | $1,024 |
| Rybelsus | 23,662 | 8.2% | $28.5 million | $1,203 |
| Liraglutide (generic) | 16,514 | 5.7% | $8.0 million | $484 |
| Zepboundapproved for weight management | 1,937 | 0.7% | $2.0 million | $1,049 |
| Victoza | 1,417 | 0.5% | $1.1 million | $778 |
| Wegovyapproved for weight management | 1,109 | 0.4% | $1.5 million | $1,310 |
| Bydureon | 20 | 0.0% | $16,007 | $800 |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
On Medicare in Illinois?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
Illinois and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
2 of the 5 states next to Illinois cover GLP-1s for weight loss through Medicaid: Missouri and Wisconsin. None has a lower cash floor than Illinois's $39.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| Illinois | Not covered | 19 | $39/mo |
| Indiana | Not covered | 19 | $39/moWellmedr |
| Iowa | Not covered | 19 | $39/moWellmedr |
| Kentucky | Not covered | 19 | $39/moWellmedr |
| Missouri | Zepbound only | 18 | $39/moWellmedr |
| Wisconsin | Zepbound only | 19 | $39/moWellmedr |






















